Similarly, miR-144 in BMSC-Exos could down-regulate the expression levels of CCNE1 and CCNE2, thereby regulating the cell proliferation and cell cycle progression in non-small cell lung cancer (NSCLC), and further inhibiting NSCLC progression (Liang et al., 2020). Here, CCNE2 is linked to non-small cell lung carcinoma.